1. The amino acid compositions of human fibrinogen and three intermediate anticoagulant derivatives were determined by column chromatography. The derivatives were isolated by ammonium sulphate fractionation and column electrophoresis from solutions of fibrinogen undergoing spontaneous breakdown. One derivative, isolated as the large electrophoretic peak at the end of the clottable period (100% CP) of the parent fibrinogen solution, was labelled LP1oo and others obtained at twice this period (200% CP) were designated as LP200 and SP200 (LP, large peak; SP, small peak). 2. Maximal 'molecular' weights of approx. 294000 for LPloo, 137 000 for LP200 and 37000 for SP200 were calculated for the protein moieties. At least 265 amino acid residues must have been lost from each fibrinogen molecule during the formation of LPloo, and 1362 during the formation of the other two derivatives. 3. Only one derivative (LP200) had a partial specific volume (vU 0-725ml./g.) different from that of fibrinogen (v 0.721ml./g.). 4 . No significant differences in refractive index at 589m, were detected. & Calculation of the total number of ionizable groups/105g. of each protein moiety showed a preponderance of the following numbers of negative charges: 22 in fibrinogen; 24 in LP1oo; 26 in LP200; 49 in SP200. The isoionic points were estimated to be approx.+ 0-03pH unit (for fibrinogen), -0O06pIEL unit for (LPloo) and +0-28pH unit (for LP200) from the pK of imidazole, and 0.78pH unit above the average pK of aspartyl and glutamyl ions (for SP200). These figures agree closely with experimentally determined values of the isoelectric point of fibrinogen and its derivatives.
Numerous studies have been concerned with fibrinogen, because of the fundamental role of this protein in blood coagulation. The search for an effective way to treat thrombosis and prevent embolism has given impetus to the study of fibrinolysis and indirectly to that offibrinogenolysis. The interest in these processes became even greater when it was discovered that the products of fibrinogenolysis have anticoagulant properties (Triantaphyllopoulos, 1958; Niewiarowski & Kowalski, 1958) . Most of the studies of these anticoagulants have been concerned with their mode ofaction, their electrophoretic, ultracentrifugal or immunological properties, their detection or their isolation from blood (Triantaphyllopoulos, 1958 (Triantaphyllopoulos, , 1959 (Triantaphyllopoulos, , 1960 KQwalski, Budzynski, Kopec & Murawski, 1960; Niisenzweig, Seligmann, Pelmont & Grabar, 1961a; Nussenzweig, Seligmann & Grabar, 1961b; Triantaphyllopoulos & Triantaphyllopoulos, 1962 , 1965a ,b, 1966a Schwick, 1963) . We have shown that the antithrombic activity, electrophoretic mobility and thermosensitivity ofthe main anticoagulant fraction vary greatly with the stage of incubation of the parent fibrinogen solution (Triantaphyllopoulos & Triantaphyllopoulos, 1965a ,b, 1966b . The greatest inhibitory effect is exhibited by preparations that are isolated at the time when the parent fibrinogen becomes completely unclottable by thrombin. This variability reflects a continuous change in the composition or tertiary structure or both of the anticoagulant. Information on structural changes is almost non-existent; there is only one report on the amino acid composition of a fibrinogen derivative, which was obtained from bovine fibrinogen after complete fragmentation by trypsin (Mihalyi & Godfrey, 1963) .
We are primarily interested in the study of fibrinogen-derived anticoagulants that are produced under conditions resembling as closely as possible the ones prevailing in human blood. There, fibrinogen is believed to be broken down by fibrinolysin (plasmin) after activation of the endogenous 393 profibrinolysin (plasminogen). In the present studies, human fibrinogen was allowed to lyse spontaneously under sterile conditions; the main anticoagulant products were isolated at two different stages of incubation, and the amino acid compositions of these fractions were determined under the same conditions as those used to find the composition of the parent intact fibrinogen. From the amino acid content and the yield of each anticoagulant, and from accepted values for the molecular weight and carbohydrate content of human fibrinogen, the maximal 'molecular' weight and the molar amino acid composition ofthe protein moiety of each anticoagulant derivative was estimated. Knowledge of the amino acid composition ofthese fractions further allowed the calculation of apparent specific volumes, refractive indices and the nature and number of charged groups; from the last-named data, approximate isoionic points could be found.
It has been reported (Finlayson & Mosesson, 1963; Mosesson & Finlayson, 1963 ) that human fibrinogen of high purity [fraction I-4 (Blomback & Blomback, 1956 ); lysine-treated fraction I-4 (Mosesson, 1962) ] can be separated by chromatography on DEAE-cellulose into two fractions. Both of these fractions can be clotted by thrombin. They show the same sedimentation rate, u.v. absorption spectrum, N-terminal amino acids, phosphorus content and sialic acid content, and seem identical immunologically. We have similarly detected two components in preparations of human and bovine fibrinogen of high clottability, and in preparations of the main anticoagulant obtained from them (Triantaphyllopoulos & Triantaphyllopoulos, 1965a,b) . Since these fibrinogen fractions are nearly identical, some believe that they are artifacts (Godal & Luscher, 1960 (Triantaphyllopoulos & Triantaphyllopoulos, 1965a strands after the addition of thrombin to samples of the incubated solution and dilution of the mixtures 1 :2 with water. The duration of this period depends on the fibrinolytic activity of each preparation. In the experiments described here, it lasted for 4-5 days.
Anticoagulant fractions LPloo, LP200 and SP200. The fibrinogen was incubated at 370, under sterile conditions, in solutions of 10mg./ml., buffered with imidazole to pH 7.3, as described in detail earlier (Triantaphyllopoulos & Triantaphyllopoulos, 1965a) . Fractionations were performed: (a) at the end of the clottable period (100% CP), when the antithrombic activity of the produced anticoagulants is always at its maximum; (b) at twice this period (200% CP), when the antithrombic activity is considerably lower but still higher than the activity of the final products (Triantaphyllopoulos & Triantaphyllopoulos, 1965a) . The incubation period in each experiment was expressed as a percentage of the clottable period (CP) to eliminate differences in the rate of fibrinogenolysis (Triantaphyllopoulos & Triantaphyllopoulos, 1965a (Triantaphyllopoulos& Triantaphyllopoulos, 1966b) , in 0-02M-veronal buffer, pH 8-6. The main subfractions from each preparation, emerging from the column as a large and a small peak, were collected and concentrated by freeze-drying. They were designated:
LP1oo, large peak obtained from preparations that were isolated at 100% CP; LP200, large peak from preparations isolated at 200% CP; SP200, small peak from preparations isolated at 200% CP. It is not possible to separate smallpeak material at 100% CP. The large-peak fractions correspond to the ac-derivative described by Seegers, Nieft & Vandenbelt (1945) , and the small peak component is the ,8-derivative described by these authors. The subfractions were kept as dry powders at -20°. Before hydrolysis a portion was dissolved in a small volume of water and dialysed against a large volume of 0.85% NaCl with continuous stirring, to remove veronal. Dialysis was completed within 4-8hr. after three or four changes of 0-85% NaCl. The protein content of each solution was determined by the biuret method of Kingsley for total protein (Hawk, Oser & Summerson, 1954 Human fibrinogen,96-98% clottable, was incubatedat 37°and pH 7.3 understerile conditions. Anticoagulant fractions were isolated by 25-50% saturation with (NH4)2SO4 and column electrophoresis at the following times: (a) the end of the clottable period (100% CP); (b) twice the length of this period (200% CP) . The electrophoretic fractions, large peak from 100% CP (LP1oo), large peak from 200% CP (LP200) and small peak from 200% CP (SP200), were hydrolysed with 6w-HCI in vacuo at 1100. Amino acid analyses were performed in a Beckman model 120 amino acid analyser by the method of Spackman et al. (1958) . Tryptophan was determined spectrophotometrically (Bencze & Schmid, 1957) . Results are given as mean + S.D. Percentages were calculated from the number ofresidues in 100g. ofprotein multiplied by residue weight. The number ofatoms ofN contributed by each amino acid were added and multiplied by 14 x 100/sum ofresidue weights, to obtain the percentage of amino acid N. The total percentages are not exactly 100 because of experimental error. For the percentage amino acid composition, corrected to 100% total, see Table 4 . of protein/mg. of fibrinogen. This is well below the limit that can be determined by the ninhydrin method. It is safe therefore to conclude that all the amino acid residues that were detected in these analyses belong to fibrinogen and the fibrinogen fractions.
The percentage (w/w) of each amino acid residue in human fibrinogen and its derivatives is shown on the right half of Table 1 . Ammonia was calculated with aspartic acid as asparagine. The final result is independent ofwhether this substance is counted as asparagine or glutamine (Cohn, 1965 
DISCUSSION
The amino acid composition of human fibrinogen presented by Tristram (1949) was obtained from the data ofBailey (1944) and Brand & Edsall (1947) . These analyses were performed at a time when neither were sufficiently purified preparations of fibrinogen available [Brand & Edsall (1947) residues/105g.). The disagreement in these amino acids may be due to the following: (a) differences in the methods of isolation of human fibrinogen used in each Laboratory; (b) differences in the determination procedures; Henschen & BlombAck (1964) used a common calibration standard (,-2-thienylalanine) for all the amino acids. Charges and iwoionic points. There are no free SH groups in fibrinogen, and, since S S bonds can be detected only after denaturation (Carter & Warner, 1954; Henschen, 1964) , all the cystine residues must be occupied in disulphide bridges and be unable to contribute any charges. (Mihalyi et al. 1964 ). Electrophoretic studies with purified preparations have given values of 5.5-5.95, depending on the nature of the buffer and the ionic strength of the solution (Seegers et al. 1945; Sheppard & Wright, 1954; Abe, Sheppard & Wright, 1955) . From measurements of the g-potentials,
-Wright & associates calculated a value of 5*8 at zero ionic strength. Mihalyi et al. (1964) , on the other hand, on the basis of their data on the amino acid composition of bovine fibrinogen, have suggested that the isoelectric point of this protein should be approx. 9. Calculation of the balance of charges in human fibrinogen from our corrected data (Table 4) shows that, after complete dissociation of the dicarboxylic acid residues that are not bound as glutamine or asparagine, there will be an excess of 9-5 positive charges in human fibrinogen. Equilibrium will be attained when an equal number of imidazolium ions have become uncharged. This will occur at about 0 03pH unit from the pK value of this ion [pH=pK+log(9.5/8.8)].
The pK value of the imidazolium ion in proteins has been found to vary between 5-6 and 7 0 (Edsall, 1965) . Proteins bind anions and cations to a different extent, and their net charge in solution will be influenced by the nature of the buffer electrolytes and the ionic strength of the solution. Isoelectric points of 5-5 to 5 95 can all be compatible with the amino acid composition of fibrinogen presented in Table 1 . The values of the isoelectric point suggest that the pK of the imidazolium ion in fibrinogen is close to the lower limits recorded for this ion. The value calculated by Abe et al. (1955) for zero ionic strength, considered together with the logarithm of the ratio of the uncharged to the charged residues of histidine (0.03), points to a pK value of about 5 8.
Similar calculations indicate that the isoionic points of LPLoo and LP200 should be about pH5.7
and 6-1 respectively, if the pK of the imidazolium ion in these derivatives is the same as in fibrinogen.
Seegers et al. (1945) , working with acetate, phosphate and borate buffers, found an isoelectric point of approx. 655 for their a-derivative, which corresponds to our LP from the final stages of incubation. The amino acid composition of SP200 Suggests that the isoionic point of this anticoagulant must be approx. 0.76pH unit above the average pK value of the aspartyl and glutamyl ions. Seegers et al. (1945) have shown that the isoelectric point of the ,-derivative (SP from the final stages of incubation) is approx. 4-2. The average pK value of the side carboxyl groups of the two carboxy amino acids in this protein must therefore be close to pH 3*4.
Maximal molecular weight8. The 2j% of the original protein that was precipitated at 0-25% saturation with ammonium sulphate (Table 2) must be composed of fibrinogen molecules that were in a rather early stage of lysis since they were still precipitated at the same salt saturation as intact fibrinogen. The 57% that formed the 25-50%-saturated ammonium sulphate fraction must have come from the remaining 97.5% ofthe protein. This fraction must then represent 57 x 100/97.5 = 58.5% of the fibrinogen molecules. Since SP200 and LP200 make up 20% and 73% of the 25-50%-saturated ammonium sulphate fraction respectively (Table 3) , SP200 must represent 58-5 x 20/100=11.7% and LP200 42.7% of the parent molecule. The accepted value for the molecular weight of fibrinogen is 340000 (Caspary & Kekwick, 1957) , with a carbohydrate content of about 5% (Blomback, 1958) .
The weight of the protein moiety must be approx. 323 000. One mole of this moiety must therefore have produced 323 000 x 11.7/100 = approx. 38 000g. Of SP200 and 323000 x 42.7/100= 138000g. of LP200.
Comparison of the amino acid composition of LP100 with that of fibrinogen (values adjusted for 105g. of protein exactly) showed that the concentration of isoleucine in the derivative increased more than the concentration of any other amino acid. This indicates that very few, if any, residues of isoleucine were removed from fibrinogen during the formation of LP1oo. If we assume that no residues of isoleucine were removed at all, the 35-5 (adjusted value) residues of this amino acid that were detected in 105g. of LP100 must 
